Table 4.
Correlations between the relative contents of serum fatty acids and acute phase proteins in morbidly obese subjects studied (n = 21).
Fatty acids | ORM | CRP | Albumin | CRP/ Albumin |
---|---|---|---|---|
SFA | ||||
C12:0 (lauric acid)a | −0.48* | −0.44* | 0.07 | −0.38 |
C14:0 (myristic acid)a | −0.26 | −0.29 | −0.21 | −0.19 |
C16:0 (palmitic acid)a | 0.20 | 0.10 | −0.20 | 0.14 |
C17:0 (margaric acid)b | −0.09 | −0.57* | 0.58* | −0.59* |
C18:0 (stearic acid)a | −0.19 | 0.03 | 0.11 | 0.03 |
MUFA | ||||
C16:1 n-7 (palmitoleic acid)a | −0.10 | 0.24 | 0.08 | 0.18 |
C18:1 n-9 (oleic acid)a | 0.14 | 0.23 | −0.07 | 0.19 |
n-3 PUFA | ||||
C20:5 n-3 (EPA)b | −0.46* | −0.29 | 0.51* | −0.33 |
C22:6 n-3 (DHA)a | −0.07 | −0.14 | 0.06 | −0.12 |
n-6 PUFA | ||||
C18:2 n-6 (linoleic acid)b | 0.19 | 0.41 | −0.41 | 0.39 |
C20:4 n-6 (AA)a | 0.46* | 0.01 | −0.11 | 0.01 |
n-6/n-3a | 0.46* | 0.26 | −0.24 | 0.25 |
AA/EPAa | 0.59* | 0.22 | −0.32 | 0.23 |
PUFA/SFAa | 0.42 | 0.22 | −0.12 | 0.20 |
AA: arachidonic acid; CRP: C-reactive Protein; EPA: eicosapentaenoic acid; DHA: docosahexaenoic acid; ORM: orosomucoid; MUFA: monounsaturated fatty acids; PUFA: Polyunsaturated fatty acids; SFA: saturated fatty acids.
*P < 0.05, aPearson's correlation, bSpearman's correlation.